These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 2192157

  • 1. [Clinical significance of antimitotic spindle-associated antibody assay].
    Obayashi H, Wada T, Fukui I, Nakayama A.
    Nihon Rinsho; 1990 Feb; 48 Suppl():599-602. PubMed ID: 2192157
    [No Abstract] [Full Text] [Related]

  • 2. Anti-NuMA antibodies: an uncommon specificity in scleroderma sera.
    Herrera-Esparza R, Avalos-Diaz E, Barbosa-Cisneros O.
    Rev Rhum Engl Ed; 1999 Jun; 66(6):315-8. PubMed ID: 10418059
    [Abstract] [Full Text] [Related]

  • 3. Antibody to the mitotic spindle apparatus: immunologic characteristics and cytologic studies.
    McCarty GA, Valencia DW, Fritzler MJ.
    J Rheumatol; 1984 Apr; 11(2):213-8. PubMed ID: 6374139
    [Abstract] [Full Text] [Related]

  • 4. Identification and characterization of a protein associated with the stembody using autoimmune sera from patients with systemic sclerosis.
    Kingwell B, Fritzler MJ, Decoteau J, Rattner JB.
    Cell Motil Cytoskeleton; 1987 Apr; 8(4):360-7. PubMed ID: 3319199
    [Abstract] [Full Text] [Related]

  • 5. [Clinical significance of anticentromere antibody assay].
    Moteki S.
    Nihon Rinsho; 1990 Feb; 48 Suppl():580-3. PubMed ID: 2192153
    [No Abstract] [Full Text] [Related]

  • 6. [Diagnosis of systemic scleroderma].
    Guĭda PP.
    Klin Med (Mosk); 1983 Jun; 61(6):82-5. PubMed ID: 6887774
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Autoantibodies and clinical subsets: relevance to scleroderma.
    Maddison PJ.
    Wien Klin Wochenschr; 2000 Aug 25; 112(15-16):684-6. PubMed ID: 11020957
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical aspects of progressive systemic scleroderma (PSS). Multicenter studies of 194 patients].
    Goerz G, Hammer G, Wirth G, Hornstein OP, Keller GJ, Altmeyer P, Holzmann H, Meigel W, Mensing H, Braun-Falco O.
    Hautarzt; 1986 Jun 25; 37(6):320-4. PubMed ID: 3522484
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Raynaud's phenomenon and anti-centromeric antibodies].
    Marquet R, Villar MM, Ordi J, de la Figuera M, Vilardell M.
    Med Clin (Barc); 1984 Jun 16; 83(3):129-30. PubMed ID: 6482556
    [No Abstract] [Full Text] [Related]

  • 18. Epidemiology and clinical associations of NuMA (nuclear mitotic apparatus protein) autoantibodies.
    Auer-Grumbach P, Achleitner B.
    J Rheumatol; 1994 Sep 16; 21(9):1779-81. PubMed ID: 7799375
    [No Abstract] [Full Text] [Related]

  • 19. The identification of mammalian centrosomal antigens using human autoimmune anticentrosome antisera.
    Balczon R, West K.
    Cell Motil Cytoskeleton; 1991 Sep 16; 20(2):121-35. PubMed ID: 1751966
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.